Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Dual Therapy for H. pylori Eradication
NCT02553083Phase 4Unknown
- Sponsor
- Rabin Medical Center
- Start
- Oct 2015
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, amoxicillin, doxycycline in Helicobacter pylori infection, sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
esomeprazoleamoxicillindoxycycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02553083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02553083.